• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. FEMORAL HEAD BIOLOX DELTA CERAMIC 12/14 - 28 L; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. FEMORAL HEAD BIOLOX DELTA CERAMIC 12/14 - 28 L; HIP COMPONENT Back to Search Results
Model Number PHA04406
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Pain (1994)
Type of Reportable Event Serious Injury
Event or Problem Description
Information from clinical study # (b)(6): patient #65 reported the following adverse events: pain.This adverse event did not end up in revision surgery.
 
Additional Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluated.
 
Additional Manufacturer Narrative
The alleged complaint could not be confirmed.Mpo was made aware of this incident through a clinical study performed using mpo implants.This incident occurred on (b)(6) 2017.It was reported that no revision surgery was required.These implants were not returned for investigation, nor were any pictures provided to assist with the investigation.Medical data was provided; however, the data did not contain the lot numbers for the implants.It is unknown when these implants were manufactured, or if they were manufactured to specification due to the unknown lot number.There are no trends for these implants and failures, however, there has been an increase in complaints involving profemur® z classic femoral stems.A review of these complaints reveal that they have all been reported due to this clinical study.It cannot be concluded what the level of contribution, if any, that the product had to the complaint.No further evaluations can be made without return of the product or receipt of other clinical information.The mpo hip systems package insert (150803-9) lists pain as a potential adverse effect of total hip arthroplasty.Additionally, it also states periodic, long-term follow-up is recommended to monitor the position and state of the prosthetic components, as well as the condition of the adjoining bone.Periodic post-operative x-rays are recommended for close comparison with early post op conditions to detect long term evidence of changes in position, loosening, bending, or cracking of components.Mpo will continue to monitor this issue through complaint tracking.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMORAL HEAD BIOLOX DELTA CERAMIC 12/14 - 28 L
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
Manufacturer Contact
rachael wise
5677 airline road
arlington, TN 38002
9018674771
MDR Report Key21324418
Report Number3010536692-2025-00039
Device Sequence Number18122252
Product Code LZO
UDI-Device IdentifierM684PHA044061
UDI-PublicM684PHA044061
Combination Product (Y/N)N
Initial Reporter CountryIT
PMA/510(K) Number
K140043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberPHA04406
Device Catalogue NumberPHA04406
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/15/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date02/06/2025
Supplement Report FDA Received Date12/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-